Most cited papers in Biological Research and Disease Studies
What are the most cited papers in Biological Research and Disease Studies?
The most cited paper in Biological Research and Disease Studies is "The global prevalence of dementia: A systematic review and metaanalysis" (Martin James Prince, Renata Bryce, Emiliano Albanese et al., 2013), with 4,986 citations. Next come "Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement" (4,836) and "NanoPack: visualizing and processing long-read sequencing data" (3,475).
Showing 50 of 100 papers. Every paper with more than 582 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The global prevalence of dementia: A systematic review and metaanalysis Martin James Prince, Renata Bryce, Emiliano Albanese et al. · Alzheimer s & Dementia | 2013 | 4,986 |
| 2 | Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement David Moher, Deborah J Cook, Susan Eastwood et al. · The Lancet | Nov 1999 | 4,836 |
| 3 | NanoPack: visualizing and processing long-read sequencing data Wouter De Coster, Svenn D’Hert, Darrin T. Schultz et al. · Bioinformatics | 12 Mar 2018 | 3,475 |
| 4 | Donanemab in Early Symptomatic Alzheimer Disease John Randall Sims et al. · JAMA | 17 Jul 2023 | 2,880 |
| 5 | Alzheimer disease in the United States (2010–2050) estimated using the 2010 census Liesi E. Hebert, Jennifer Weuve, Paul A. Scherr et al. · Neurology | 7 Feb 2013 | 2,721 |
| 6 | An Overview of Autophagy: Morphology, Mechanism, and Regulation Katherine R. Parzych, Daniel J. Klionsky · Antioxidants and Redox Signaling | 3 Jun 2013 | 2,585 |
| 7 | Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses Lise Lotte Kjaergard, John Villumsen, Christian Nyfeldt Gluud · Annals of Internal Medicine | 4 Dec 2001 | 2,341 |
| 8 | Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Amelia M. Bartholomew, Cord Sturgeon, Mandy Siatskas et al. · Experimental Hematology | 2002 | 2,297 |
| 9 | Alzheimer Disease in the US Population Liesi E. Hebert, Paul A. Scherr, Julia L. Bienias et al. · Archives of Neurology | Aug 2003 | 2,183 |
| 10 | Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Toshiyuki Miyashita, Stanisław Krajewski, Maryla Krajewska et al. · PubMed | Jun 1994 | 2,164 |
| 11 | Tumor spectrum analysis in p53-mutant mice Tyler Jacks, Lee Ann Remington, Bart O. Williams et al. · Current Biology | 1994 | 2,095 |
| 12 | In Silico Approach for Predicting Toxicity of Peptides and Proteins Sudheer Gupta, Pallavi Kapoor, Kumardeep Chaudhary et al. · PLoS ONE | 13 Sep 2013 | 2,078 |
| 13 | Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Clifford R. Jack, Marilyn Albert, David S. Knopman et al. · Alzheimer s & Dementia | 22 Apr 2011 | 2,073 |
| 14 | Detection of Various Microplastics in Human Stool Philipp Schwabl, Sebastian Köppel, Philipp Königshofer et al. · Annals of Internal Medicine | 2 Sep 2019 | 1,956 |
| 15 | The global burden of typhoid fever. John A. Crump, Stephen P. Luby, Eric D. Mintz · PubMed | May 2004 | 1,955 |
| 16 | Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis Jørn Wetterslev, Kristian Thorlund, Jesper Sune Brok et al. · Journal of Clinical Epidemiology | 24 Aug 2007 | 1,929 |
| 17 | Depression and poor glycemic control: a meta-analytic review of the literature. Patrick J. Lustman, Ryan J. Anderson, Kenneth E. Freedland et al. · Diabetes Care | Jul 2000 | 1,861 |
| 18 | Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Barton F. Haynes et al. · New England Journal of Medicine | 4 Apr 2012 | 1,851 |
| 19 | Alzheimer’s disease drug-development pipeline: few candidates, frequent failures Jeffrey L. Cummings, Travis Morstorf, Kate Zhong · Alzheimer s Research & Therapy | 3 Jul 2014 | 1,787 |
| 20 | Antiretroviral Therapy for the Prevention of HIV-1 Transmission Myron S. Cohen et al. · New England Journal of Medicine | 18 Jul 2016 | 1,760 |
| 21 | Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 Sean F. Altekruse, Katherine A. McGlynn, Marsha E. Reichman · Journal of Clinical Oncology | 17 Feb 2009 | 1,702 |
| 22 | Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease Rachelle Smith Doody, Ronald G. Thomas, Martin Rhys Farlow et al. · New England Journal of Medicine | 22 Jan 2014 | 1,675 |
| 23 | Infection with chikungunya virus in Italy: an outbreak in a temperate region Giovanni Rezza, Loredana Nicoletti, Paola Angelini et al. · The Lancet | Dec 2007 | 1,536 |
| 24 | Diagnosis and Management of Dementia: Review Zoe Arvanitakis, Raj C. Shah, David Alan Bennett · JAMA | 22 Oct 2019 | 1,452 |
| 25 | Dose escalation of a curcuminoid formulation Christopher D. Lao, Mack T. Ruffin, Daniel Paul Normolle et al. · BMC Complementary and Alternative Medicine | 17 Mar 2006 | 1,398 |
| 26 | Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes Marlene L. Durand, Stephen B. Calderwood, David Jay Weber et al. · New England Journal of Medicine | 7 Jan 1993 | 1,369 |
| 27 | Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource Donald B. Smith, Jens Bukh, Carla Kuiken et al. · Hepatology | 11 Oct 2013 | 1,365 |
| 28 | Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood Wolfgang Wagner, Frederik Wein, Anja Seckinger et al. · Experimental Hematology | Nov 2005 | 1,266 |
| 29 | Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors Manel Esteller · JNCI Journal of the National Cancer Institute | 5 Apr 2000 | 1,238 |
| 30 | Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women Breast Cancer Association Consortium · New England Journal of Medicine | 20 Jan 2021 | 1,192 |
| 31 | Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials Jacques LeLorier, Geneviève Grégoire, A Aïssa Benhaddad et al. · New England Journal of Medicine | 21 Aug 1997 | 1,188 |
| 32 | Type 2 Diabetes and its Impact on the Immune System Afiat Berbudi, Nofri Rahmadika, Adi Imam Tjahjadi et al. · Current Diabetes Reviews | 28 Oct 2019 | 1,167 |
| 33 | Interventions to Enhance Patient Adherence to Medication Prescriptions Heather McDonald, Amit X. Garg, Robert Brian Haynes · JAMA | 11 Dec 2002 | 1,141 |
| 34 | Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation Paola Fioretto, Michael W. Steffes, David E.R. Sutherland et al. · New England Journal of Medicine | 9 Jul 1998 | 1,141 |
| 35 | World Journal of Microbiology and Biotechnology 2008 Lynn G. Dover, Peter J. Large, Nasib Qureshi et al. · World Journal of Microbiology and Biotechnology | 14 Jul 2008 | 1,132 |
| 36 | Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Bernard J. Escudier, Tim G Eisen, Walter Michael Stadler et al. · Journal of Clinical Oncology | 18 May 2009 | 1,089 |
| 37 | Prevalence and Severity of Food Allergies Among US Adults Ruchi S. Gupta, Christopher Michael Warren, Bridget Smith et al. · JAMA Network Open | 4 Jan 2019 | 1,036 |
| 38 | Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Mark J. Ratain, Tim G Eisen, Walter Michael Stadler et al. · Journal of Clinical Oncology | 24 Apr 2006 | 1,036 |
| 39 | The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis Nader Salari, Hooman Ghasemi, Loghman Mohammadi et al. · Journal of Orthopaedic Surgery and Research | 17 Oct 2021 | 1,032 |
| 40 | Multiple Sclerosis: Current Knowledge and Future Outlook Christian P. Kamm, Bernard M.J. Uitdehaag, Chris H. Polman · European Neurology | 2014 | 1,017 |
| 41 | Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine | 16 Dec 1999 | 1,010 |
| 42 | Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa Lisa M. Saiman, Bruce C. Marshall, Nicole Mayer-Hamblett et al. · JAMA | 30 Sep 2003 | 961 |
| 43 | Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America Luis Angel Villar et al. · New England Journal of Medicine | 3 Nov 2014 | 958 |
| 44 | Folic Acid for the Prevention of Colorectal Adenomas Bernard F. Cole et al. · JAMA | 5 Jun 2007 | 935 |
| 45 | Diagnosis and Treatment of Alzheimer Disease and Related Disorders Gary W. Small · JAMA | 22 Oct 1997 | 934 |
| 46 | Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason et al. · Journal of Clinical Oncology | Aug 1999 | 907 |
| 47 | Lifetime Cancer Risks in Individuals with GermlinePTENMutations Min-Han Tan, Jessica L. Mester, Joanne Yuen Yie Ngeow et al. · Clinical Cancer Research | 15 Jan 2012 | 900 |
| 48 | Purification of human erythropoietin. Takahito Miyake, Charles K.-H. Kung, Eugene Goldwasser · Journal of Biological Chemistry | Aug 1977 | 896 |
| 49 | A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. Jon M. Huibregtse, Martin Scheffner, Peter M. Howley · The EMBO Journal | Dec 1991 | 893 |
| 50 | Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study Barbara Ann Burtness, Meredith A. Goldwasser, William A. Flood et al. · Journal of Clinical Oncology | 28 Nov 2005 | 885 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.